Languages

  1. Research
  2. Publications

Publications

Filters: Author is Bandelow, B and Keyword is Humans  [Clear All Filters]
2003
Broocks A, Meyer T, Opitz M, et al. "5-HT1A responsivity in patients with panic disorder before and after treatment with aerobic exercise, clomipramine or placebo." Eur Neuropsychopharmacol. 2003;13(3):153-64.
2001
Broocks A, Meyer T, Gleiter CH, et al. "Effect of aerobic exercise on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine and to ipsapirone in untrained healthy subjects." Psychopharmacology (Berl.). 2001;155(3):234-41.
2000
Bandelow B, Broocks A, Pekrun G, et al. "The use of the Panic and Agoraphobia Scale (P & A) in a controlled clinical trial." Pharmacopsychiatry. 2000;33(5):174-81.
1999
Broocks A, Meyer T, George A, et al. "Decreased neuroendocrine responses to meta-chlorophenylpiperazine (m-CPP) but normal responses to ipsapirone in marathon runners." Neuropsychopharmacology. 1999;20(2):150-61.
1998
Broocks A, Bandelow B, Pekrun G, et al. "Comparison of aerobic exercise, clomipramine, and placebo in the treatment of panic disorder." Am J Psychiatry. 1998;155(5):603-9.
Meyer T, Broocks A, Bandelow B, Hillmer-Vogel U, Rüther E. "Endurance training in panic patients: spiroergometric and clinical effects." Int J Sports Med. 1998;19(7):496-502.
1997
Broocks A, Meyer TF, Bandelow B, et al. "Exercise avoidance and impaired endurance capacity in patients with panic disorder." Neuropsychobiology. 1997;36(4):182-7.